ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000092.1|Megalomicin_2 # 2072 # 3382 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=7bp;gc_cont=0.706	BGC0000092.1|Megalomicin_2 	2072	3382	+	Loose	700	51.2174	oleI	33.98	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTCGTGTTTTCATCGATGGCTGTCAACAGCCATCTGTTCGGGCTGGTCCCGCTCGCAAGCGCCTTCCAGGCGGCCGGACACGAGGTACGGGTCGTCGCCTCGCCGGCCCTGACCGACGACGTCACCGGTGCCGGTCTGACCGCCGTGCCCGTCGGTGACGACGTGGAACTTGTGGAGTGGCACGCCCACGCGGGCCAGGACATCGTCGAGTACATGCGGACCCTCGACTGGGTCGACCAGAGCCACACCACCATGTCCTGGGACGACCTCCTGGGCATGCAGACCACCTTCACCCCGACCTTCTTCGCCCTGATGAGCCCCGACTCGCTCATCGACGGGATGGTCGAGTTCTGCCGCTCCTGGCGTCCCGACTGGATCGTCTGGGAGCCGCTGACCTTCGCCGCCCCGATCGCGGCCCGGGTCACCGGAACCCCGCACGCCCGGATGCTGTGGGGTCCGGACGTCGCCACCCGGGCCCGGCAGAGCTTCCTGCGACTGCTGGCCCACCAGGAGGTGGAGCACCGGGAGGATCCGCTGGCCGAGTGGTTCGACTGGACGCTGCGGCGCTTCGGCGACGACCCGCACCTGAGCTTCGACGAGGAACTGGTGCTGGGGCAGTGGACCGTGGACCCCATCCCCGAGCCGCTGCGGATCGACACCGGCGTCCGGACGGTGGGCATGCGGTACGTCCCCTACAACGGCCCCTCGGTGGTGCCCGCCTGGCTGTTGCGGGAACCCGAACGTCGGCGGGTCTGCCTGACCCTCGGCGGTTCCAGCCGGGAACACGGCATCGGGCAGGTCTCCATCGGCGAGATGTTGGACGCCATCGCCGACATCGACGCCGAGTTCGTGGCCACCTTCGACGACCAGCAGTTGGTCGGCGTGGGCAGCGTTCCGGCAAACGTCCGTACCGCCGGGTTCGTGCCGATGAACGTCCTGCTGCCCACCTGCGCGGCCACCGTGCACCACGGCGGCACCGGCAGTTGGCTGACCGCCGCCATCCACGGCGTACCGCAGATCATCCTCTCGGACGCCGACACCGAGGTGCACGCCAAGCAGCTCCAGGACCTCGGCGCGGGGCTGTCGCTCCCGGTCGCGGGGATGACCGCCGAGCACCTGCGTGGGGCGATCGAGCGGGTTCTCGACGAGCCGGCGTACCGCCTCGGTGCGGAGCGGATGCGGGACGGGATGCGGACCGACCCGTCGCCGGCCCAGGTGGTCGGCATCTGTCAGGACCTGGCCGCCGACCGGGCGGCACGCGGCAGGCAGCCGCGTCGAACCGCCGAGCCGCACCTGCCGCGATGA	MRVVFSSMAVNSHLFGLVPLASAFQAAGHEVRVVASPALTDDVTGAGLTAVPVGDDVELVEWHAHAGQDIVEYMRTLDWVDQSHTTMSWDDLLGMQTTFTPTFFALMSPDSLIDGMVEFCRSWRPDWIVWEPLTFAAPIAARVTGTPHARMLWGPDVATRARQSFLRLLAHQEVEHREDPLAEWFDWTLRRFGDDPHLSFDEELVLGQWTVDPIPEPLRIDTGVRTVGMRYVPYNGPSVVPAWLLREPERRRVCLTLGGSSREHGIGQVSIGEMLDAIADIDAEFVATFDDQQLVGVGSVPANVRTAGFVPMNVLLPTCAATVHHGGTGSWLTAAIHGVPQIILSDADTEVHAKQLQDLGAGLSLPVAGMTAEHLRGAIERVLDEPAYRLGAERMRDGMRTDPSPAQVVGICQDLAADRAARGRQPRRTAEPHLPR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	102.83	gnl|BL_ORD_ID|1684|hsp_num:0	1824			897	1206	oleandomycin
BGC0000092.1|Megalomicin_3 # 3462 # 4634 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.651	BGC0000092.1|Megalomicin_3 	3462	4634	+	Loose	200	34.2686	vanT gene in vanC cluster	29.6	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	GTGGTTACCTCCACCAACTTGGACACGACAGCACGGCCGGCACTGAACTCGTTGACCGGGATGCGGTTCGTCGCCGCCTTCCTGGTCTTCTTCACGCACGTCCTGTCGAGGCTCATCCCGAACAGCTACGTGTACGCCGACGGCCTGGACGCCTTCTGGCAGACCACCGGACGGGTGGGGGTGTCGTTCTTCTTTATTCTCAGCGGTTTCGTGCTGACCTGGTCGGCGCGGGCCAGCGACTCGGTGTGGTCGTTCTGGCGCAGACGGGTCTGCAAGCTCTTCCCCAACCACCTGGTCACCGCCTTCGCCGCCGTGGTGTTGTTCCTGGTCACCGGGCAGGCGGTGAGCGGTGAGGCGCTGATCCCGAACCTCCTGCTGATCCACGCCTGGTTCCCGGCCCTGGAGATCTCCTTCGGCATCAACCCGGTGAGCTGGTCGTTGGCCTGCGAGGCGTTCTTCTACCTGTGCTTCCCGCTGTTCCTGTTCTGGATCTCCGGTATCCGCCCGGAGCGGCTGTGGGCCTGGGCCGCCGTGGTGTTCGCCGCGATCTGGGCGGTACCGGTGGTCGCCGACCTCCTGCTGCCGAGTTCCCCGCCGCTGATCCCGGGGCTTGAGTACTCCGCCATCCAGGACTGGTTCCTCTACACCTTCCCTGCGACGCGGAGCCTGGAGTTCATCCTCGGGATCATCCTGGCCCGCATCCTGATCACCGGTCGGTGGATCAACGTCGGGCTGCTCCCCGCGGTGCTGTTGTTCCCGGTCTTCTTCGTCGCCTCGCTCTTCCTGCCGGGTGTCTACGCCATCTCCTCGTCGATGATGATCCTTCCCCTGGTTCTGATCATCGCCAGCGGCGCGACGGCCGACCTCCAGCAGAAGCGCACCTTCATGCGTAACCGGGTGATGGTGTGGCTCGGCGACGTCTCCTTCGCGCTCTACATGGTCCACTTCCTGGTGATCGTCTACGGGGCGGACCTGCTGGGGTTCAGCCAGACCGAGGACGCCCCGCTGGGTCTCGCACTCTTCATGATCATTCCGTTCCTCGCGGTCTCCCTGGTGCTGTCGTGGCTGCTGTACAGGTTCGTCGAGCTACCCGTCATGCGTAACTGGGCCCGCCCGGCCTCCGCCCGGCGCAAACCCGCCACGGAACCCGAACAGACCCCTTCCCGCCGGTAA	MVTSTNLDTTARPALNSLTGMRFVAAFLVFFTHVLSRLIPNSYVYADGLDAFWQTTGRVGVSFFFILSGFVLTWSARASDSVWSFWRRRVCKLFPNHLVTAFAAVVLFLVTGQAVSGEALIPNLLLIHAWFPALEISFGINPVSWSLACEAFFYLCFPLFLFWISGIRPERLWAWAAVVFAAIWAVPVVADLLLPSSPPLIPGLEYSAIQDWFLYTFPATRSLEFILGIILARILITGRWINVGLLPAVLLFPVFFVASLFLPGVYAISSSMMILPLVLIIASGATADLQQKRTFMRNRVMVWLGDVSFALYMVHFLVIVYGADLLGFSQTEDAPLGLALFMIIPFLAVSLVLSWLLYRFVELPVMRNWARPASARRKPATEPEQTPSRR	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	55.87	gnl|BL_ORD_ID|4675|hsp_num:0	734			27	384	vancomycin
BGC0000092.1|Megalomicin_4 # 4651 # 5775 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.679	BGC0000092.1|Megalomicin_4 	4651	5775	+	Loose	500	27.335	mphJ	28.09	3004544	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGACCACCTACGTCTGGTCCTATCTGTTGGAGTACGAGAGGGAACGAGCCGACATCCTCGATGCGGTGCAGAAGGTCTTCGCCAGTGGCAGCCTGATCCTCGGTCAGAGTGTGGAGAACTTCGAGACCGAGTACGCCCGCTACCACGGGATCGCGCACTGCGTGGGCGTCGACAACGGCACCAACGCTGTGAAACTCGCGCTGGAGTCGGTAGGTGTCGGACGCGACGACGAGGTCGTCACGGTCTCCAACACCGCCGCCCCCACAGTCCTGGCCATCGACGAGATCGGCGCCCGGCCGGTCTTCGTGGACGTCCGCGACGAGGACTACCTCATGGACACCGACCTGGTGGAGGCGGCGGTCACCCCGCGTACCAAGGCCATCGTCCCGGTGCACCTGTACGGGCAGTGCGTGGACATGACAGCCCTGCGGGAACTGGCCGACCGGCGGGGCCTCAAGCTCGTGGAGGACTGCGCCCAGGCCCACGGTGCCCGGCGGGACGGTCGGCTGGCCGGGACGATGAGCGACGCGGCGGCCTTCTCGTTCTACCCGACGAAGGTCCTCGGCGCCTACGGCGACGGCGGCGCGGTCGTCACCAACGACGACGAGACAGCCCGCGCCCTGCGACGGCTGCGGTACTACGGGATGGAGGAGGTCTACTACGTCACCCGGACCCCGGGTCACAACAGCCGCCTCGACGAGGTGCAGGCCGAGATCCTGCGGCGCAAACTGACCCGGCTCGACGCGTACGTCGCGGGTCGGCGGGCGGTCGCCCAGCGGTACGTCGACGGGCTCGCCGACCTCCAAGACTCGCACGGCCTCGAACTCCCAGTGGTCACCGACGGCAACGAACACGTCTTCTACGTGTACGTCGTCCGCCACCCGCGCCGCGACGAGATCATCAAGCGTCTCCGGGACGGGTACGACATCTCCCTGAACATCAGCTACCCCTGGCCGGTGCACACCATGACCGGCTTCGCCCACCTCGGTGTCGCGTCGGGGTCGCTGCCGGTCACCGAACGGCTGGCCGGCGAGATCTTCTCCCTTCCCATGTACCCCTCCCTCCCTCACGACCTGCAGGACAGGGTGATCGAGGCGGTGCGGGAGGTCATCACCGGGCTGTGA	MTTYVWSYLLEYERERADILDAVQKVFASGSLILGQSVENFETEYARYHGIAHCVGVDNGTNAVKLALESVGVGRDDEVVTVSNTAAPTVLAIDEIGARPVFVDVRDEDYLMDTDLVEAAVTPRTKAIVPVHLYGQCVDMTALRELADRRGLKLVEDCAQAHGARRDGRLAGTMSDAAAFSFYPTKVLGAYGDGGAVVTNDDETARALRRLRYYGMEEVYYVTRTPGHNSRLDEVQAEILRRKLTRLDAYVAGRRAVAQRYVDGLADLQDSHGLELPVVTDGNEHVFYVYVVRHPRRDEIIKRLRDGYDISLNISYPWPVHTMTGFAHLGVASGSLPVTERLAGEIFSLPMYPSLPHDLQDRVIEAVREVITGL	MSKNNVEHMLALAKNNGILVDPTTVKVNESGLDFLAIFASTIDGIPWVLRQPRRDDVVETARYEKRVLDLVAKHLRVEVPDWQVHTSEFIAYPILGGTPMATINMETKNYDWYLNPESLPELCIQTWAEALVELHGIHHDLARDAGIRVKQPSYARASLREKMNEIKRVFGVSGALWDRWQKWLADETFWPAHSALVHGDLHPGHILVAENGKVTGLLDWTEAEVSDPAIDFTVVYLLFGDTGLADFIQRYEKAGGRVWSRMHEHIVEMTAAYPVTLATFALKSGLEEFKIMARQALGVDENGKEITS	121.43	gnl|BL_ORD_ID|2691|hsp_num:0	3220			138	402	erythromycin; telithromycin; tylosin
BGC0000092.1|Megalomicin_5 # 5822 # 6595 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.708	BGC0000092.1|Megalomicin_5 	5822	6595	+	Loose	550	31.5722	RlmA(II)	26.04	3001301	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGCCGAACAGCCACTCGACCACGTCGAGCACCGACGTCGCCCCGTACGAGCGGGCGGACATCTACCACGACTTCTACCACGGCCGTGGCAAGGGATACCGTGCCGAAGCCGACGCGCTCGTGGAGGTCGCCCGCAAGCACACCCCACAGGCGGCGACCCTGCTGGACGTGGCCTGCGGGACCGGATCCCACCTGGTCGAGCTGGCGGACAGCTTCCGGGAGGTGGTGGGGGTCGACCTGTCGGCCGCCATGCTCGCCACCGCCGCCCGCAACGACCCCGGGCGGGAACTGCACCAGGGCGACATGCGCGACTTCTCCCTCGACCGCAGGTTCGACGTCGTCACCTGCATGTTCAGCTCCACCGGTTACCTCGTCGACGAGGCCGAACTGGACCGTGCCGTGGCGAACCTGGCCGGTCACCTCGCGCCTGGCGGCACCCTCGTCGTGGAGCCCTGGTGGTTCCCGGAGACGTTCCGGCCCGGCTGGGTCGGGGCCGACCTGGTCACCAGCGGTGACCGGAGGATCTCCCGGATGTCGCACACCGTCCCGGCGGGTCTGCCCGACCGCACCGCCTCCCGGATGACCATCCACTACACGGTGGGGTCACCGGAGGCCGGGATCGAGCACTTCACCGAGGTGCACGTGATGACCCTGTTCGCCCGCGCCGCCTACGAGCAGGCCTTCCAGCGGGCGGGCCTGAGCTGCTCGTACGTCGGCCACGACCTGTTCTCGCCGGGCCTTTTCGTCGGGGTCGCCGCGGAGCCGGGGCGGTGA	MPNSHSTTSSTDVAPYERADIYHDFYHGRGKGYRAEADALVEVARKHTPQAATLLDVACGTGSHLVELADSFREVVGVDLSAAMLATAARNDPGRELHQGDMRDFSLDRRFDVVTCMFSSTGYLVDEAELDRAVANLAGHLAPGGTLVVEPWWFPETFRPGWVGADLVTSGDRRISRMSHTVPAGLPDRTASRMTIHYTVGSPEAGIEHFTEVHVMTLFARAAYEQAFQRAGLSCSYVGHDLFSPGLFVGVAAEPGR	MNTNLKPKLQRFASATAFACPICQENLTLLETNFKCCNRHSFDLAKFGYVNLAPQIKQSANYNKENFQNRQQILEAGFYQAILDAVSDLLASSKTTTTILDIGCGEGFYSRKLQESHSEKTFYAFDISKDSVQIAAKSEPNWAVNWFVGDLARLPIKDANMDILLDIFSPANYGEFRRVLSKDGILIKVIPTENHLKEIRQRVQDQLTNKEYSNQDIKEHFQEHFTILSSQTASLTKTITAEQLQALLSMTPLLFHVDQSKIDWSQLTEITIEAEILVGKAF	91.13	gnl|BL_ORD_ID|2052|hsp_num:0	2274			234	519	tylosin; mycinamicin
BGC0000092.1|Megalomicin_7 # 7220 # 8206 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000092.1|Megalomicin_7 	7220	8206	+	Loose	900	26.5646	iri	31.58	3002884	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin monooxygenase	GTGGTGGTGCTCGGCGCGTCGGGTTTCCTGGGTTCGGCGGTCACCCACGCCCTGGCCGACCTCCCGGTGCGGGTGCGGCTCGTCGCCCGGCGGGAGGTCGTCGTGCCCTCCGGTGCCGTCGCCGACTACGAGACGCACCGGGTGGACCTCACCGAACCCGGAGCGCTCGCGGAGGTGGTCGCGGACGCCCGGGCGGTCTTCCCGTTCGCCGCCCAGATCAGGGGTACGTCAGGGTGGCGGATCAGCGAGGACGACGTGGTCGCCGAACGGACGAACGTCGGCCTGGTCCGGGACCTGATCGCCGTCCTGTCCCGCTCGCCGCACGCCCCGGTGGTGGTCTTCCCGGGCAGCAACACGCAGGTCGGCAGGGTCACCGCCGGCCGGGTCATCGACGGCAGCGAGCAGGACCACCCCGAGGGCGTCTACGACAGGCAGAAACACACCGGGGAACAGCTGCTCAAGGAGGCCACTGCGGCCGGGGCGATCCGGGCGACCAGTCTGCGGCTGCCCCCGGTGTTCGGGGTGCCCGCCGCCGGCACCGCCGACGACCGGGGGGTGGTCTCCACCATGATCCGTCGGGCCCTGACCGGCCAACCGCTGACGATGTGGCACGACGGCACCGTCCGGCGTGAACTGCTGTACGTGACCGACGCCGCCCGGGCCTTCGTCACCGCCCTGGACCACGCCGACGCGCTCGCCGGACGCCACTTCCTGTTGGGGACGGGGCGTTCCTGGCCGCTGGGCGAGGTCTTCCAGGCGGTCTCGCGCAGCGTCGCCCGGCACACCGGCGAGGACCCGGTGCCGGTGGTCTCGGTGCCGCCTCCGGCGCACATGGACCCGTCGGACCTGCGCAGCGTGGAGGTCGACCCCGCCCGGTTCACGGCTGTCACCGGGTGGCGGGCCACGGTCACGATGGCGGAGGCGGTCGACCGGACGGTGGCGGCGTTGGCCCCCCGCCGGGCCGCCGCCCCGTCCGAGCCCTCCTGA	MVVLGASGFLGSAVTHALADLPVRVRLVARREVVVPSGAVADYETHRVDLTEPGALAEVVADARAVFPFAAQIRGTSGWRISEDDVVAERTNVGLVRDLIAVLSRSPHAPVVVFPGSNTQVGRVTAGRVIDGSEQDHPEGVYDRQKHTGEQLLKEATAAGAIRATSLRLPPVFGVPAAGTADDRGVVSTMIRRALTGQPLTMWHDGTVRRELLYVTDAARAFVTALDHADALAGRHFLLGTGRSWPLGEVFQAVSRSVARHTGEDPVPVVSVPPPAHMDPSDLRSVEVDPARFTAVTGWRATVTMAEAVDRTVAALAPRRAAAPSEPS	MSDVIIVGAGPTGLMLAGELRLQGVDVVVVDKDEEPTQFVRALGIHVRSIEIMEQRGLLDKFLAHGRKYPLGGFFAGISKPAPAHLDTAHGYVLGIPQPEIDRILAEHATEVGADIQRGKRVVAIRQDTDNVAAELSDGTTLHARYLVGCDGGRSTVRKLRSTSVFPASRTSADTLIGEMDVTMPADELAAVVAEIRETHKRFGVGPAGNGAFRVVVPAAEVADGRATPTTLDDIKQQLLAIAGTDFGVHSPRWLSRFGDATRLADDYRRDRVFLAGDAAHIHPPMGGQGLNLGVQDAFNLGWKLAAEINGWAPVGLLDTYESERRPVAADVLDNTRAQAELISTAAGPQAVRRLISELMEFEDVKRYLTEKITAISIRYDFGEGDDLLGRRLRNIALTRGNLYDLMRSGRGLLLDQGGQLSVDGWSDRADHIVDTSTELEAPAVLLRPDGHVAWIGDAQAELDTQLSTWFGRSARDRA	68.48	gnl|BL_ORD_ID|729|hsp_num:0	796			183	297	rifampin; rifaximin; rifabutin; rifapentine
BGC0000092.1|Megalomicin_9 # 9226 # 10479 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.711	BGC0000092.1|Megalomicin_9 	9226	10479	-	Loose	700	59.3066	oleI	33.33	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGCGGGTCCTGCTCACCTCGTTCGCGCACCGTACCCACTTCCAGGGCCTCGTCCCCCTGGCCTGGGCGCTGCACACCGCCGGCCACGACGTCCGGGTGGCCAGTCAGCCCGAGCTCACCGACGTCGTCGTCGGCGCGGGACTGACCTCGGTGCCACTCGGCTCGGACCACCGACTCTTCGACATCTCCCCTGAGGCCGCCGCGCAGGTGCACCGCTACACCACCGACCTGGACTTCGCCCGACGCGGACCGGAACTGCGCTCGTGGGAGTTCCTGCACGGCATCGAGGAGGCCACCTCCCGGTTCGTCTTCCCGGTGGTCAACAACGACTCCTTCGTCGACGAACTCGTCGAGTTCGCCATGGACTGGCGTCCCGACCTGGTGCTCTGGGAGCCCTTCACCTTCGCCGGGGCGGTCGCGGCCAAGGCCTGCGGGGCCGCCCACGCCCGGCTGCTGTGGGGCAGCGACCTCACCGGCTACTTCCGCAGCCGCTCCCAGGACCTGCGCGGGCAGCGTCCCGCCGACGACCGGCCGGACCCGCTCGGCGGCTGGCTCACCGAGGTCGCCGGCCGGTTCGGCCTCGACTACAGCGAGGACCTCGCTGTCGGACAGTGGAGCGTCGACCAGCTGCCCGAGAGCTTCCGCCTGGAGACCGGACTGGAGTCGGTGCACACCCGGACTTTGCCCTACAACGGGTCCTCCGTCGTGCCGCAGTGGCTCAGGACCTCGGACGGAGTCCGCCGGGTCTGCTTCACCGGGGGATACTCGGCGCTGGGCATCACCTCGAACCCGCAGGAGTTCCTCCGGACACTGGCCACCCTCGCGCGGTTCGACGGCGAGATCGTGGTGACCCGCTCCGGGCTCGATCCGGCGTCGGTGCCGGACAACGTCCGCCTGGTGGACTTCGTTCCCATGAACATCCTGCTGCCGGGCTGTGCCGCCGTCATCCACCACGGCGGTGCCGGAAGCTGGGCCACCGCGCTGCACCACGGCGTACCGCAGATCTCCGTCGCCCACGAGTGGGACTGTGTCCTGCGTGGTCAGCGCACCGCCGAGCTGGGAGCGGGTGTCTTCCTCCGTCCGGACGAGGTCGACGCCGACACCCTCTGGCAGGCTCTCGCCACAGTGGTCGAGGACCGTTCCCACGCCGAGAACGCCGAGAAGCTGCGGCAGGAGGCGCTGGCCGCGCCGACCCCCGCCGAGGTCGTACCCGTGCTGGAGGCGCTCGCCCACCAGCACCGCGCCGACAGGTGA	MRVLLTSFAHRTHFQGLVPLAWALHTAGHDVRVASQPELTDVVVGAGLTSVPLGSDHRLFDISPEAAAQVHRYTTDLDFARRGPELRSWEFLHGIEEATSRFVFPVVNNDSFVDELVEFAMDWRPDLVLWEPFTFAGAVAAKACGAAHARLLWGSDLTGYFRSRSQDLRGQRPADDRPDPLGGWLTEVAGRFGLDYSEDLAVGQWSVDQLPESFRLETGLESVHTRTLPYNGSSVVPQWLRTSDGVRRVCFTGGYSALGITSNPQEFLRTLATLARFDGEIVVTRSGLDPASVPDNVRLVDFVPMNILLPGCAAVIHHGGAGSWATALHHGVPQISVAHEWDCVLRGQRTAELGAGVFLRPDEVDADTLWQALATVVEDRSHAENAEKLRQEALAAPTPAEVVPVLEALAHQHRADR	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	98.35	gnl|BL_ORD_ID|1684|hsp_num:0	1824			810	1206	oleandomycin
BGC0000092.1|Megalomicin_10 # 10483 # 11079 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.720	BGC0000092.1|Megalomicin_10 	10483	11079	-	Loose	1200	28.1054	arnA	22.92	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGCTCCTGTTCGCCAGCACCACCCAGGCCGCGAACCCCGCCGCCCCCAGCCGGTACGCCCAGCACAAGATCGAGGCCGAGCGGATCCTGCGTCAGGCCACCGAGGACGGGGTCGTCGACGGGGTGATCCTGCGCCTGCCCGCGATCTACGGCCACAGCGGCCCGTCGGGGCAGACCGGCCGGGGTGTCGTCACCGCCATGATCCGGCGAGCCCTCGCCGGTGAGCCGATCACGATGTGGCACGAGGGCAGCGTGCGCCGCAACCTCCTGCACGTCGAGGACGTGGCCACCGCGTTCACCGCCGCACTGCACAACCACGAGGCGCTGGTCGGCGACGTCTGGACGCCGAGCGCGGACGAGGCCCGACCCCTCGGCGAGATCTTCGAGACCGTCGCCGCCAGCGTGGCACGTCAGACCGGCAACCCTGCGGTGCCCGTCGTCAGCGTCCCTCCACCGGAGAACGCCGAGGCCAACGACTTCCGCAGCGACGACTTCGACTCCACCGAGTTCCGGACGCTGACCGGCTGGCACCCCCGGGTGCCGCTGGCCGAGGGCATCGACCGGACCGTTGCCGCCCTCATCTCGACCAAGGAGTGA	MLLFASTTQAANPAAPSRYAQHKIEAERILRQATEDGVVDGVILRLPAIYGHSGPSGQTGRGVVTAMIRRALAGEPITMWHEGSVRRNLLHVEDVATAFTAALHNHEALVGDVWTPSADEARPLGEIFETVAASVARQTGNPAVPVVSVPPPENAEANDFRSDDFDSTEFRTLTGWHPRVPLAEGIDRTVAALISTKE	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	29.91	gnl|BL_ORD_ID|1513|hsp_num:0	1643			1536	1941	polymyxin B
BGC0000092.1|Megalomicin_11 # 11209 # 11493 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.632	BGC0000092.1|Megalomicin_11 	11209	11493	+	Loose	200	23.0978	vanT gene in vanN cluster	42.86	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGCACGACGACGTCGGTGTCGGCGACGACCTGCGCGACCCGGCCGGGTTCGAGCAGGTCGACTCGAAGGTGCTCGATCCCGGCGCTGCCTGGTGGCTGGTCGCGAGACCCGGTGCGCGCGACGGCCCGCAGTCGGAGAGGGTGTGTGGTAAATTCGCGAAGAAGGGCGCTTCCGACGAATCCAGAAACGCCGAGAAGTGTGACATGTCTTGTCATCTACTAATGCATTCCGATAGCCACCGGCGCATGGAATCCATTTGTTCCCCCCAGGGTGGTGTCGGGTGA	MHDDVGVGDDLRDPAGFEQVDSKVLDPGAAWWLVARPGARDGPQSERVCGKFAKKGASDESRNAEKCDMSCHLLMHSDSHRRMESICSPQGGVG	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	13.43	gnl|BL_ORD_ID|4745|hsp_num:0	1983			1338	1401	vancomycin
BGC0000092.1|Megalomicin_12 # 11490 # 11642 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000092.1|Megalomicin_12 	11490	11642	+	Loose	500	21.557	MYX-1	55.0	3006955	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MYX beta-lactamase	GTGACAAATCCGGCCTCAGGTCGGCCTCAAGCCTCTTTCGAGCGGGTGCTGAGGCTTCCCGCGTACCCTCGGTGGCCTGCGTTCGGGCGGGTGTCGGGGAAAGGGCGGATCGAGGAGTTCGGTAGGGCGTCGCGGCGCGTACTCCGGGACTGA	MTNPASGRPQASFERVLRLPAYPRWPAFGRVSGKGRIEEFGRASRRVLRD	MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAPGVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPGAGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVVVPGHGQPGGPELLGHTEALLR	19.16	gnl|BL_ORD_ID|3707|hsp_num:0	4777			219	279	
BGC0000092.1|Megalomicin_14 # 22867 # 33555 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GAGGA;rbs_spacer=3bp;gc_cont=0.747	BGC0000092.1|Megalomicin_14 	22867	33555	+	Loose	660	77.411	MexS	34.34	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACTGACAACGACAAGGTGGCGGAGTACCTCCGTCGTGCGACGCTCGACCTGCGGGCCGCCCGCAAGCGCCTGCGCGAGCTGCAATCCGACCCGATCGCGGTCGTCGGCATGGCCTGCCGCCTACCGGGCGGGGTGCACCTCCCGCAGCACCTGTGGGACCTCCTGCGCCAGGGGCACGAGACGGTGTCCACCTTCCCCACCGGGCGCGGCTGGGACCTGGCCGGGCTCTTCCACCCGGACCCCGACCACCCCGGCACCAGCTACGTCGACCGGGGTGGGTTCCTCGACGACGTGGCGGGCTTCGACGCCGAGTTCTTCGGGATCTCCCCGCGCGAGGCCACGGCCATGGACCCGCAACAGCGGCTGCTGTTGGAGACCAGTTGGGAGCTGGTGGAGAGCGCCGGCATCGATCCGCACTCCCTGCGTGGCACCCCGACCGGCGTCTTCCTCGGCGTGGCGCGGCTCGGCTACGGCGAGAACGGCACCGAAGCCGGTGACGCCGAGGGCTATTCGGTGACCGGGGTGGCACCCGCTGTCGCCTCCGGGCGGATCTCCTACGCCCTCGGGCTGGAGGGTCCGTCGATCAGCGTGGACACCGCGTGCTCGTCGTCGTTGGTGGCGCTGCACCTGGCGGTCGAGTCGCTGCGGCTGGGCGAGTCGAGTCTCGCTGTCGTCGGCGGGGCGGCGGTCATGGCGACACCAGGGGTGTTCGTCGACTTCAGCCGCCAGCGGGCGTTGGCCGCTGACGGCAGGTCGAAGGCCTTCGGGGCCGCCGCCGACGGGTTCGGCTTCTCCGAGGGGGTCTCCCTCGTCCTGCTCGAACGGCTCTCCGAGGCCGAAAGCAACGGCCACGAGGTGTTGGCTGTCATCCGTGGCTCCGCCCTCAACCAGGACGGGGCCAGCAACGGTCTCGCCGCGCCGAACGGGACCGCCCAGCGCAAGGTGATCCGGCAGGCGCTACGAAACTGCGGCCTGACCCCGGCCGACGTGGACGCCGTGGAGGCGCACGGCACCGGCACCACGCTCGGCGACCCGATCGAGGCCAACGCCCTGCTGGACACCTACGGCCGTGACCGGGATCCGGACCACCCGCTGTGGCTGGGGTCGGTGAAGTCGAACATCGGCCACACGCAGGCGGCGGCGGGCGTCACCGGGCTGCTCAAGATGGTGCTGGCACTGCGCCACGAGGAACTGCCCGCCACCCTGCACGTCGACGAGCCCACCCCGCACGTGGACTGGTCCTCGGGAGCGGTACGCCTGGCGACCCGGGGCCGGCCGTGGCGGCGGGGTGACCGGCCGAGGCGGGCCGGGGTGTCGGCGTTCGGCATCAGCGGGACCAACGCCCACGTGATCGTCGAGGAGGCACCCGAGCGGACCACCGAGCGCACCGTCGGCGGCGACGTCGGCCCGGTCCCGCTCGTGGTGTCCGCCCGGTCGGCGGCGGCGCTACGGGCCCAGGCGGCCCAGGTCGCCGAGCTGGTGGAGGGCTCCGACGTCGGGCTGGCGGAGGTCGGGCGGAGCCTGGCCGTGACCCGGGCGCGACACGAGCACCGGGCGGCGGTGGTGGCGTCGACCCGGGCCGAGGCGGTGCGGGGGCTGCGCGAGGTCGCGGCGGTCGAACCGCGCGGCGAGGACACCGTCACCGGGGTCGCCGAGACGTCCGGGCGCACCGTCGTCTTCCTCTTCCCGGGACAGGGGTCCCAGTGGGTCGGGATGGGCGCGGAGCTGCTGGACTCGGCACCGGCGTTCGCCGACACGATCCGCGCCTGCGACGAGGCGATGGCACCGTTGCAGGACTGGTCGGTCTCCGACGTGCTCCGGCAGGAGCCGGGGGCACCGGGACTGGACCGGGTCGACGTGGTGCAGCCGGTGCTGTTCGCGGTGATGGTGTCGTTGGCGCGGTTGTGGCAGTCGTACGGGGTCACCCCCGCTGCGGTGGTGGGGCACTCGCAGGGGGAGATCGCCGCCGCCCACGTGGCGGGTGCGCTCTCCCTCGCCGACGCGGCGAGGCTGGTGGTGGGCCGCAGCCGGTTGCTGCGGTCGCTGTCCGGGGGCGGCGGCATGAGCGCCGTCGCGCTCGGTGAGGCCGAGGTACGCCGCCGACTGCGGTCGTGGGAGGACCGGATCTCCGTGGCCGCCGTCAACGGACCCCGGTCGGTGGTGGTGGCCGGGGAACCGGAGGCGCTGCGGGAGTGGGGACGGGAGCGGGAGGCCGAGGGCGTACGGGTCCGCGAGATCGACGTCGACTACGCCTCGCACTCGCCGCAGATCGACAGGGTCCGTGACGAACTCCTGACGGTCACGGGGGAGATCGAGCCCCGGTCGGCGGAGATCACCTTCTACTCGACGGTCGACGTCCGTGCTGTCGACGGCACCGACCTGGACGCGGGGTACTGGTACCGCAACCTGCGGGAGACGGTCCGGTTCGCCGACGCGATGACCCGGTTGGCCGACTCGGGATACGACGCGTTCGTCGAGGTCAGCCCGCATCCGGTGGTGGTGTCGGCGGTCGCCGAGGCGGTCGAGGAGGCAGGTGTCGAGGACGCCGTCGTCGTCGGCACCCTGTCCCGGGGCGACGGCGGACCGGGGGCGTTCCTGCGGTCGGCGGCCACCGCCCACTGCGCCGGTGTGGACGTCGACTGGACGCCCGCCCTCCCGGGAGCTGCGACGATCCCGTTGCCGACGTACCCGTTCCAACGGAAGCCGTACTGGCTGCGGTCGTCTGCTCCCGCCCCCGCCTCCCACGATCTCGCCTACCGGGTGTCCTGGACGCCGATCACCCCGCCCGGGGACGGCGTACTCGACGGCGACTGGCTGGTGGTGCACCCCGGGGGCAGCACCGGATGGGTCGACGGGTTGGCGGCGGCGATCACCGCCGGCGGTGGCCGGGTCGTCGCCCACCCGGTGGACTCCGTGACCTCCCGGACCGGCCTGGCCGAGGCGCTCGCCCGGCGGGACGGCACGTTCCGGGGGGTGCTGTCGTGGGTGGCGACCGACGAACGGCACGTCGAGGCCGGTGCGGTCGCCCTGCTGACCCTGGCGCAGGCGTTGGGTGACGCCGGAATCGACGCACCACTGTGGTGCCTGACCCAGGAGGCGGTCCGTACCCCCGTCGACGGTGACCTGGCCCGACCGGCGCAGGCCGCCCTGCACGGTTTCGCCCAGGTCGCCCGGCTGGAGCTGGCCCGCCGCTTCGGTGGGGTGCTCGACCTGCCCGCCACCGTCGACGCCGCCGGGACGCGTCTGGTCGCGGCGGTCCTCGCCGGCGGCGGCGAGGACGTCGTCGCCGTCCGTGGCGACCGTCTCTACGGCCGTCGCCTGGTCAGGGCGACCCTGCCGCCGCCCGGCGGGGGGTTCACCCCGCACGGCACCGTCCTGGTCACCGGCGCGGCCGGTCCGGTGGGCGGTCGGCTGGCCCGGTGGCTCGCCGAACGGGGTGCCACCCGACTCGTCCTGCCCGGCGCACACCCGGGCGAGGAGTTGCTGACCGCGATCCGGGCCGCCGGTGCCACCGCCGTGGTGTGCGAACCGGAGGCGGAGGCACTGCGTACGGCGATCGGCGGGGAGTTGCCGACCGCGCTCGTACACGCCGAGACGTTGACGAACTTCGCCGGCGTCGCCGACGCCGACCCCGAGGACTTCGCCGCCACCGTCGCGGCGAAGACCGCGCTGCCGACGGTCCTGGCGGAGGTGCTCGGCGACCACCGCCTCGAACGGGAGGTCTACTGCTCGTCGGTGGCCGGGGTCTGGGGTGGGGTCGGCATGGCCGCGTACGCCGCCGGCAGCGCCTACCTCGACGCCCTGGTCGAGCACCGTCGCGCCCGGGGGCACGCCAGCGCCTCGGTGGCCTGGACCCCGTGGGCCCTGCCCGGCGCGGTCGACGACGGTCGGCTGCGCGAGCGCGGCCTGCGCAGCCTCGACGTGGCCGACGCCCTCGGGACGTGGGAACGTCTGCTCCGCGCCGGTGCGGTGTCGGTGGCCGTCGCCGACGTCGACTGGTCGGTCTTCACAGAGGGTTTCGCGGCCATCCGGCCGACCCCGCTCTTCGACGAACTCCTCGACCGGCGCGGGGACCCCGACGGCGCGCCCGTCGACCGGCCGGGGGAGCCGGCGGGCGAGTGGGGTCGACGAATCGCGGCGCTGTCCCCGCAGGAACAGCGGGAGACGTTGCTGACCCTCGTCGGCGAGACGGTCGCGGAGGTGCTGGGACACGAGACCGGCACCGAGATCAACACCCGTCGGGCCTTCAGCGAACTCGGCCTCGACTCGCTGGGCTCGATGGCCCTGCGTCAGCGCCTGGCGGCCCGTACCGGCCTGCGGATGCCGGCCTCGCTGGTCTTCGACCACCCGACGGTCACCGCGCTCGCGCGGTACCTGCGTCGACTGGTCGTCGGGGACTCCGACCCGACCCCGGTACGGGTGTTCGGCCCCACCGACGAGGCCGAACCCGTCGCCGTGGTCGGCATCGGCTGCCGGTTCCCCGGCGGCATCGCCACCCCCGAGGACCTCTGGCGGGTGGTGTCCGAGGGCACCTCCATCACCACCGGATTCCCCACCGACCGGGGCTGGGACCTCCGGCGGCTCTACCACCCCGACCCGGACCACCCCGGCACCAGCTACGTCGACAGGGGGGGATTCCTCGACGGGGCCCCGGACTTCGACCCCGGGTTCTTCGGGATCACCCCCCGCGAGGCGCTGGCGATGGACCCGCAGCAGCGGCTCACCCTGGAGATCGCGTGGGAGGCGGTGGAACGGGCGGGCATCGACCCGGAGACCCTCCTCGGCAGCGACACCGGCGTCTTCGTCGGCATGAACGGCCAGTCCTACCTGCAACTGCTGACCGGGGAGGGTGACCGGCTCAACGGCTACCAGGGGTTGGGCAACTCGGCGAGCGTGCTCTCCGGCCGTGTCGCCTACACCTTCGGGTGGGAGGGGCCGGCGCTGACGGTGGACACCGCCTGCTCGTCCTCGCTGGTCGCCATCCACCTCGCCATGCAGTCGCTGCGTCGGGGTGAGTGCTCGCTGGCGTTGGCCGGCGGGGTGACGGTCATGGCCGACCCGTACACCTTCGTGGACTTCAGCGCACAGCGGGGGCTCGCCGCCGACGGGCGGTGCAAGGCGTTCTCCGCGCAGGCCGACGGGTTCGCCCTCGCCGAGGGCGTCGCGGCGCTCGTCCTCGAACCGTTGTCCAAGGCGCGGCGAAACGGCCACCAGGTGCTGGCGGTGCTGCGCGGCAGCGCCGTCAACCAGGACGGGGCCAGCAACGGCCTCGCCGCCCCGAACGGGCCGTCGCAGGAACGGGTGATCAGGCAGGCCCTGACCGCCTCCGGGCTGCGTCCCGCCGACGTCGACATGGTGGAGGCGCACGGGACGGGCACCGAACTCGGCGACCCGATCGAGGCCGGGGCGCTCATCGCGGCGTACGGCCGGGACCGGGACCGGCCGCTCTGGCTGGGCTCGGTGAAGACGAACATCGGCCACACCCAGGCCGCCGCCGGTGCCGCCGGGGTGATCAAGGCGGTCCTGGCGATGCGGCACGGCGTACTCCCGAGGTCGCTGCACGCCGACGAGTTGTCCCCGCACATCGACTGGGCGGACGGGAAGGTCGAGGTGCTCCGCGAGGCACGACAGTGGCCCCCCGGTGAGCGCCCCCGCCGCGCCGGGGTGTCCTCCTTCGGCGTCAGCGGGACCAACGCCCACGTCATCGTCGAGGAGGCACCCGCCGAACCGGACCCCGAACCGGTTCCCGCCGCCCCGGGCGGGCCCCTGCCCTTCGTCCTGCACGGACGCAGCGTCCAGACGGTCCGGTCCCAGGCGCGGACCCTCGCCGAACACCTGCGCACCACCGGCCACCGGGACCTCGCCGACACCGCCCGTACCCTGGCCACCGGTCGCGCCCGTTTCGACGTCCGGGCCGCAGTGCTCGGCACCGACCGGGAGGGTGTCTGCGCCGCCCTCGACGCGCTGGCGCAGGATCGCCCCTCGCCCGACGTCGTCGCCCCGGCGGTCTTCGCCGCCCGTACCCCCGTCCTGGTCTTCCCCGGGCAGGGGTCGCAGTGGGTCGGCATGGCCCGTGACCTGCTCGACTCCTCCGAGGTGTTCGCCGAGTCGATGGGCCGGTGCGCCGAGGCGCTGTCGCCGTACACCGACTGGGACCTGCTCGACGTGGTCCGTGGGGTCGGCGACCCCGACCCGTACGACCGGGTGGACGTGCTCCAGCCGGTGCTGTTCGCGGTGATGGTGTCGCTGGCGCGGTTGTGGCAGTCGTACGGGGTGACTCCGGGTGCGGTGGTGGGTCACTCGCAGGGGGAGATCGCCGCCGCGCACGTGGCTGGTGCGTTGTCGTTGGCCGACGCCGCCAGGGTGGTGGCGTTGCGCAGCCGGGTGCTGCGGGAGCTCGACGACCAGGGCGGCATGGTGTCGGTCGGCACCTCCCGCGCCGAGTTGGACTCGGTCCTGCGCCGGTGGGACGGGCGGGTCGCGGTGGCGGCGGTGAACGGACCCGGCACGCTCGTGGTGGCCGGACCCACCGCCGAACTGGACGAGTTCCTCGCGGTGGCCGAGGCCCGCGAGATGAGGCCGCGTCGGATCGCGGTGCGCTACGCGTCGCACTCCCCGGAGGTGGCCCGGGTCGAACAGCGGCTCGCCGCCGAACTCGGCACCGTCACCGCCGTCGGCGGCACGGTCCCGCTCTACTCCACCGCCACCGGGGACCTCCTCGACACCACAGCCATGGACGCCGGGTACTGGTACCGCAACCTGCGCCAACCGGTGCTGTTCGAGCACGCCGTCCGCAGCCTCCTGGAGCGGGGATTCGAGACGTTCATCGAGGTCAGCCCGCACCCTGTGCTGCTGATGGCGGTCGAGGAGACCGCCGAGGACGCCGAGCGCCCGGTCACCGGCGTGCCGACGCTGCGCCGCGACCACGACGGGCCGTCGGAGTTCCTCCGCAACCTCCTGGGGGCGCACGTGCACGGGGTCGACGTCGACCTGCGTCCGGCGGTCGCCCACGGCCGCCTGGTCGACCTGCCCACCTACCCCTTCGACAGGCAGCGGCTCTGGCCCAAGCCGCACCGCAGGGCCGACACCTCGTCGCTGGGGGTCCGTGACTCGACCCACCCGCTGCTGCACGCCGCAGTCGACGTACCCGGTCACGGCGGAGCGGTGTTCACCGGGCGGCTCTCCCCCGACGAGCAGCAGTGGCTGACCCAGCACGTGGTGGGTGGGCGGAACCTGGTGCCCGGCAGTGTCCTGGTCGACCTCGCGCTCACCGCCGGGGCCGACGTCGGCGTGCCGGTGCTGGAGGAACTCGTCCTGCAGCAGCCGCTGGTGTTGACCGCCGCCGGTGCGTTGCTGCGCCTGTCGGTCGGCGCCGCCGACGAGGACGGGCGGCGGCCGGTCGAGATCCACGCCGCCGAGGACGTCTCCGACCCGGCCGAGGCCCGGTGGTCGGCGTACGCGACCGGGACCCTCGCCGTCGGCGTGGCCGGCGGCGGCCGGGACGGCACACAGTGGCCCCCGCCCGGCGCCACCGCCCTGACGTTGACCGACCACTACGACACCCTCGCCGAACTGGGCTACGAGTACGGGCCGGCGTTCCAGGCGCTGCGCGCCGCGTGGCAGCACGGCGACGTGGTCTACGCGGAGGTGTCCCTCGACGCCGTCGAGGAGGGGTACGCGTTCGACCCGGTGCTGCTCGACGCCGTCGCCCAGACCTTCGGCCTGACCAGTCGCGCCCCCGGGAAGCTCCCCTTCGCCTGGCGGGGCGTCACCCTGCACGCCACCGGGGCCACTGCGGTACGGGTGGTGGCGACCCCCGCCGGACCGGACGCGGTGGCCCTGCGGGTCACCGACCCGACCGGTCAGCTCGTCGCCACGGTGGACGCCCTGGTCGTCAGGGACGCCGGGGCGGATCGGGACCAGCCGCGCGGCCGCGACGGCGACCTGCACCGCCTGGAGTGGGTACGGCTGGCCACCCCGGACCCGACCCCGGCGGCGGTGGTGCACGTGGCGGCCGACGGGCTCGACGACCTGCTGCGCGCCGGTGGTCCGGCACCACAGGCCGTCGTCGTCCGCTACCGTCCCGACGGCGACGACCCGACGGCCGAGGCCCGTCACGGGGTGCTCTGGGCGGCCACGCTCGTGCGCCGTTGGCTCGACGACGACCGGTGGCCCGCCACCACCCTGGTGGTGGCCACGTCCGCAGGGGTCGAGGTCTCCCCCGGGGACGACGTGCCGCGCCCCGGGGCCGCCGCCGTGTGGGGGGTGCTGCGCTGCGCCCAGGCGGAGTCCCCGGACCGCTTCGTGCTCGTCGACGGCGACCCGGAGACGCCCCCGGCGGTGCCGGACAATCCGCAGCTCGCGGTCCGTGACGGTGCGGTGTTCGTGCCACGGCTGACGCCGCTCGCCGGTCCCGTGCCGGCCGTCGCCGACCGGGCGTACCGGCTGGTGCCCGGCAACGGCGGCTCCATCGAGGCAGTGGCCTTCGCCCCCGTCCCCGACGCCGACCGGCCCCTGGCGCCGGAGGAGGTACGCGTCGCCGTCCGCGCCACCGGCGTGAACTTCCGTGACGTCCTGCTCGCGCTCGGCATGTACCCGGAACCGGCCGAGATGGGCACCGAGGCGTCCGGTGTGGTCACCGAGGTCGGGTCGGGTGTCCGGCGGTTCACCCCCGGCCAGGCGGTGACGGGCCTGTTCCAGGGGGCCTTCGGGCCGGTGGCGGTCGCCGACCACCGGCTCCTCACCCCGGTCCCCGACGGGTGGCGGGCGGTGGACGCCGCAGCCGTACCCATCGCGTTCACCACCGCCCACTACGCGCTGCACGACCTGGCCGGGTTGCAGGCCGGGCAGTCCGTGCTGGTCCACGCCGCCGCCGGCGGGGTGGGGATGGCTGCCGTCGCGTTGGCCCGTCGGGCCGGGGCGGAGGTGTTCGCCACGGCCAGCCCGGCCAAACACCCGACGCTGCGGGCGCTCGGCCTCGACGACGACCACATCGCCTCGTCCCGGGAGAGCGGGTTCGGTGAGCGGTTCGCCGCGCGTACCGGGGGGCGGGGCGTCGACGTGGTCCTGAACTCGCTCACCGGCGACCTGCTCGACGAGTCCGCGCGGCTGCTCGCCGACGGCGGGGTCTTCGTCGAGATGGGCAAGACCGACCTGCGGCCGGCGGAGCAGTTCCGGGGCCGGTACGTCCCGTTCGACCTGGCCGAGGCCGGTCCCGATCGGCTCGGCGAGATCCTGGAGGAGGTCGTCGGTCTGCTGGCCGCCGGTGCCCTCGACCGGTTGCCGGTGTCGGTGTGGGAGTTGTCGGCGGCCCCGGCCGCGCTCACCCACATGAGCCGGGGCCGACACGTGGGCAAGCTCGTCCTCACCCAGCCCGCCCCCGTGCACCCCGACGGAACGGTGCTGGTCACCGGCGGGACCGGCACCCTGGGGCGGCTGGTCGCCCGCCACCTGGTGACCGGGCACGGCGTACCCCACCTCCTGGTGGCCAGCCGGCGCGGTCCGGCGGCCCCGGGCGCGGCCGAGCTGCGCGCCGACGTCGAAGGCCTCGGCGCGACCATCGAGATCGTCGCCTGCGACACCGCCGACCGGGAGGCGCTCGCGGCGCTGCTCGACTCGATCCCCGCGGACCGTCCGCTGACCGGGGTGGTGCACACCGCCGGGGTCCTGGCCGACGGGCTGGTCACCTCCATCGACGGGACCGCCACCGATCAGGTCCTGCGGGCCAAGGTCGACGCGGCGTGGCACCTGCACGACCTGACCCGGGACGCGGACCTGAGCTTCTTCGTGCTGTTCTCGTCGGCGGCGTCGGTGCTGGCCGGTCCCGGGCAGGGCGTGTACGCGGCGGCCAACGGGGTCCTCAACGCCCTGGCCGGGCAACGGCGGGCCCTCGGACTGCCCGCGAAGGCGCTCGGGTGGGGCCTGTGGGCGCAGGCCAGCGAGATGACCAGCGGCCTCGGTGACCGGATCGCCCGTACCGGGGTCGCCGCGCTGCCGACCGAGCGGGCGCTGGCCCTGTTCGACGCGGCTCTGCGCAGCGGCGGGGAGGTGCTGTTCCCGCTGTCTGTCGACAGGTCGGCGCTGCGCCGGGCCGAGTACGTCCCCGAGGTGCTGCGCGGCGCGGTCCGGTCCACGCCACGGGCCGCCAACAGGGCCGAGACCCCGGGCCGGGGCCTGCTCGACCGTCTCGTCGGTGCACCCGAGACCGATCAGGTGGCCGCGCTGGCCGAGCTGGTCCGCTCGCACGCGGCGGCGGTCGCCGGCTACGACTCGGCCGACCAGCTGCCCGAACGCAAGGCGTTCAAGGACCTCGGGTTCGACTCGCTGGCGGCGGTGGAGCTGCGCAACCGGCTCGGCGTCACCACCGGCGTACGGCTGCCCAGCACGCTGGTGTTCGACCACCCGACACCGCTGGCGGTGGCCGAACACCTGCGGTCGGAGTTGTTCGCCGACTCCGCGCCGGACGTCGGGGTCGGTGCGCGCCTCGACGACCTGGAACGGGCGCTCGACGCCCTGCCCGACGCGCAGGGACACGCCGACGTCGGGGCCCGCCTGGAGGCGCTGCTGCGCCGGTGGCAGAGCCGACGACCCCCGGAGACCGAGCCAGTGACGATCAGTGACGACGCCAGTGACGACGAGCTGTTCTCGATGCTCGACAGGCGTCTCGGCGGGGGAGGGGACGTCTAG	VTDNDKVAEYLRRATLDLRAARKRLRELQSDPIAVVGMACRLPGGVHLPQHLWDLLRQGHETVSTFPTGRGWDLAGLFHPDPDHPGTSYVDRGGFLDDVAGFDAEFFGISPREATAMDPQQRLLLETSWELVESAGIDPHSLRGTPTGVFLGVARLGYGENGTEAGDAEGYSVTGVAPAVASGRISYALGLEGPSISVDTACSSSLVALHLAVESLRLGESSLAVVGGAAVMATPGVFVDFSRQRALAADGRSKAFGAAADGFGFSEGVSLVLLERLSEAESNGHEVLAVIRGSALNQDGASNGLAAPNGTAQRKVIRQALRNCGLTPADVDAVEAHGTGTTLGDPIEANALLDTYGRDRDPDHPLWLGSVKSNIGHTQAAAGVTGLLKMVLALRHEELPATLHVDEPTPHVDWSSGAVRLATRGRPWRRGDRPRRAGVSAFGISGTNAHVIVEEAPERTTERTVGGDVGPVPLVVSARSAAALRAQAAQVAELVEGSDVGLAEVGRSLAVTRARHEHRAAVVASTRAEAVRGLREVAAVEPRGEDTVTGVAETSGRTVVFLFPGQGSQWVGMGAELLDSAPAFADTIRACDEAMAPLQDWSVSDVLRQEPGAPGLDRVDVVQPVLFAVMVSLARLWQSYGVTPAAVVGHSQGEIAAAHVAGALSLADAARLVVGRSRLLRSLSGGGGMSAVALGEAEVRRRLRSWEDRISVAAVNGPRSVVVAGEPEALREWGREREAEGVRVREIDVDYASHSPQIDRVRDELLTVTGEIEPRSAEITFYSTVDVRAVDGTDLDAGYWYRNLRETVRFADAMTRLADSGYDAFVEVSPHPVVVSAVAEAVEEAGVEDAVVVGTLSRGDGGPGAFLRSAATAHCAGVDVDWTPALPGAATIPLPTYPFQRKPYWLRSSAPAPASHDLAYRVSWTPITPPGDGVLDGDWLVVHPGGSTGWVDGLAAAITAGGGRVVAHPVDSVTSRTGLAEALARRDGTFRGVLSWVATDERHVEAGAVALLTLAQALGDAGIDAPLWCLTQEAVRTPVDGDLARPAQAALHGFAQVARLELARRFGGVLDLPATVDAAGTRLVAAVLAGGGEDVVAVRGDRLYGRRLVRATLPPPGGGFTPHGTVLVTGAAGPVGGRLARWLAERGATRLVLPGAHPGEELLTAIRAAGATAVVCEPEAEALRTAIGGELPTALVHAETLTNFAGVADADPEDFAATVAAKTALPTVLAEVLGDHRLEREVYCSSVAGVWGGVGMAAYAAGSAYLDALVEHRRARGHASASVAWTPWALPGAVDDGRLRERGLRSLDVADALGTWERLLRAGAVSVAVADVDWSVFTEGFAAIRPTPLFDELLDRRGDPDGAPVDRPGEPAGEWGRRIAALSPQEQRETLLTLVGETVAEVLGHETGTEINTRRAFSELGLDSLGSMALRQRLAARTGLRMPASLVFDHPTVTALARYLRRLVVGDSDPTPVRVFGPTDEAEPVAVVGIGCRFPGGIATPEDLWRVVSEGTSITTGFPTDRGWDLRRLYHPDPDHPGTSYVDRGGFLDGAPDFDPGFFGITPREALAMDPQQRLTLEIAWEAVERAGIDPETLLGSDTGVFVGMNGQSYLQLLTGEGDRLNGYQGLGNSASVLSGRVAYTFGWEGPALTVDTACSSSLVAIHLAMQSLRRGECSLALAGGVTVMADPYTFVDFSAQRGLAADGRCKAFSAQADGFALAEGVAALVLEPLSKARRNGHQVLAVLRGSAVNQDGASNGLAAPNGPSQERVIRQALTASGLRPADVDMVEAHGTGTELGDPIEAGALIAAYGRDRDRPLWLGSVKTNIGHTQAAAGAAGVIKAVLAMRHGVLPRSLHADELSPHIDWADGKVEVLREARQWPPGERPRRAGVSSFGVSGTNAHVIVEEAPAEPDPEPVPAAPGGPLPFVLHGRSVQTVRSQARTLAEHLRTTGHRDLADTARTLATGRARFDVRAAVLGTDREGVCAALDALAQDRPSPDVVAPAVFAARTPVLVFPGQGSQWVGMARDLLDSSEVFAESMGRCAEALSPYTDWDLLDVVRGVGDPDPYDRVDVLQPVLFAVMVSLARLWQSYGVTPGAVVGHSQGEIAAAHVAGALSLADAARVVALRSRVLRELDDQGGMVSVGTSRAELDSVLRRWDGRVAVAAVNGPGTLVVAGPTAELDEFLAVAEAREMRPRRIAVRYASHSPEVARVEQRLAAELGTVTAVGGTVPLYSTATGDLLDTTAMDAGYWYRNLRQPVLFEHAVRSLLERGFETFIEVSPHPVLLMAVEETAEDAERPVTGVPTLRRDHDGPSEFLRNLLGAHVHGVDVDLRPAVAHGRLVDLPTYPFDRQRLWPKPHRRADTSSLGVRDSTHPLLHAAVDVPGHGGAVFTGRLSPDEQQWLTQHVVGGRNLVPGSVLVDLALTAGADVGVPVLEELVLQQPLVLTAAGALLRLSVGAADEDGRRPVEIHAAEDVSDPAEARWSAYATGTLAVGVAGGGRDGTQWPPPGATALTLTDHYDTLAELGYEYGPAFQALRAAWQHGDVVYAEVSLDAVEEGYAFDPVLLDAVAQTFGLTSRAPGKLPFAWRGVTLHATGATAVRVVATPAGPDAVALRVTDPTGQLVATVDALVVRDAGADRDQPRGRDGDLHRLEWVRLATPDPTPAAVVHVAADGLDDLLRAGGPAPQAVVVRYRPDGDDPTAEARHGVLWAATLVRRWLDDDRWPATTLVVATSAGVEVSPGDDVPRPGAAAVWGVLRCAQAESPDRFVLVDGDPETPPAVPDNPQLAVRDGAVFVPRLTPLAGPVPAVADRAYRLVPGNGGSIEAVAFAPVPDADRPLAPEEVRVAVRATGVNFRDVLLALGMYPEPAEMGTEASGVVTEVGSGVRRFTPGQAVTGLFQGAFGPVAVADHRLLTPVPDGWRAVDAAAVPIAFTTAHYALHDLAGLQAGQSVLVHAAAGGVGMAAVALARRAGAEVFATASPAKHPTLRALGLDDDHIASSRESGFGERFAARTGGRGVDVVLNSLTGDLLDESARLLADGGVFVEMGKTDLRPAEQFRGRYVPFDLAEAGPDRLGEILEEVVGLLAAGALDRLPVSVWELSAAPAALTHMSRGRHVGKLVLTQPAPVHPDGTVLVTGGTGTLGRLVARHLVTGHGVPHLLVASRRGPAAPGAAELRADVEGLGATIEIVACDTADREALAALLDSIPADRPLTGVVHTAGVLADGLVTSIDGTATDQVLRAKVDAAWHLHDLTRDADLSFFVLFSSAASVLAGPGQGVYAAANGVLNALAGQRRALGLPAKALGWGLWAQASEMTSGLGDRIARTGVAALPTERALALFDAALRSGGEVLFPLSVDRSALRRAEYVPEVLRGAVRSTPRAANRAETPGRGLLDRLVGAPETDQVAALAELVRSHAAAVAGYDSADQLPERKAFKDLGFDSLAAVELRNRLGVTTGVRLPSTLVFDHPTPLAVAEHLRSELFADSAPDVGVGARLDDLERALDALPDAQGHADVGARLEALLRRWQSRRPPETEPVTISDDASDDELFSMLDRRLGGGGDV	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	1050.74	gnl|BL_ORD_ID|1039|hsp_num:0	1041			87	672	ciprofloxacin; trimethoprim; chloramphenicol
BGC0000092.1|Megalomicin_15 # 33666 # 43271 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.732	BGC0000092.1|Megalomicin_15 	33666	43271	+	Loose	500	30.4166	CTX-M-223	28.89	3005646	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CTX-M beta-lactamase	ATGAGCGAGAGCAGCGGCATGACCGAGGACCGCCTCCGGCGCTATCTCAAGCGCACCGTCGCCGAACTCGACTCGGTGACAGGTCGGCTCGACGAGGTCGAGTACCGGGCCCGCGAACCGATCGCCGTCGTCGGCATGGCCTGCCGGTTCCCCGGGGGTGTGGACTCGCCGGAGGCGTTCTGGGAGTTCATCCGCGACGGTGGTGACGCGATCGCCGAGGCGCCCACGGACCGTGGCTGGCCGCCGGCACCGCGACCCCGCCTCGGTGGTCTCCTCGCGGAGCCGGGCGCGTTCGACGCCGCCTTCTTCGGCATCTCACCCCGCGAGGCGCTCGCGACGGACCCCCAGCAGCGCCTGATGCTGGAGATCTCCTGGGAGGCGTTGGAGCGTGCGGGTTTCGACCCGTCGAGCCTGCGCGGCAGCGCCGGTGGCGTCTTCACCGGTGTCGGTGCGGTGGACTACGGACCCAGGCCGGACGAGGCACCCGAGGAGGTGCTCGGCTACGTCGGCATCGGCACCGCCTCCAGCGTCGCCTCCGGACGGGTGGCGTACACCCTGGGGTTGGAGGGTCCAGCCGTCACCGTCGACACCGCCTGCTCCTCCGGGCTCACCGCGGTGCACCTGGCGATGGAGTCGCTGCGCCGCGACGAGTGCACCCTGGTCCTCGCCGGTGGGGTCACCGTGATGAGCAGCCCGGGTGCGTTCACCGAGTTCCGCAGCCAGGGCGGGTTGGCCGAGGACGGCCGCTGCAAACCGTTCTCCCGCGCCGCCGACGGCTTCGGGCTCGCCGAGGGGGCCGGGGTCCTGGTGCTCCAACGGCTGTCCGTCGCCCGGGCCGAGGGCCGGCCGGTGCTGGCCGTACTGCGTGGCTCGGCGATCAACCAGGACGGTGCCAGCAACGGGCTCACCGCGCCGAGCGGCCCCGCCCAGCGGCGGGTGATCAGGCAGGCGTTGGAGCGGGCGCGGCTGCGTCCCGTCGACGTGGACTACGTGGAGGCCCACGGCACCGGCACCCGGCTGGGCGATCCGATCGAGGCGCACGCCCTGCTCGACACGTACGGTGCCGACCGGGAACCCGGCCGCCCGCTCTGGGTCGGATCGGTGAAGTCCAACATCGGTCACACCCAGGCGGCGGCGGGGGTGGCCGGGGTGATGAAGACCGTGCTGGCGCTGCGGCATCGGGAGATCCCGGCGACGTTGCACTTCGACGAGCCCTCGCCGCACGTCGACTGGGACCGGGGTGCGGTGTCGGTGGTGTCCGAGACCCGGCCCTGGCCGGTGGGGGAGCGCCCGCGCCGGGCGGGGGTGTCCTCGTTCGGCATCAGCGGCACCAACGCGCACGTCATCGTCGAGGAGGCGCCGAGCCCGCAGGCGGCCGACCTCGACCCGACCCCCGGCCCGGCAACCGGAGCGACCCCCGGAACGGATGCCGCCCCCACCGCCGAGCCGGGTGCGGAGGCGGTCGCACTGGTGTTCTCCGCGCGCGACGAGCGGGCCCTGCGCGCCCAGGCGGCCCGGCTCGCCGACCGTCTCACCGACGACCCGGCCCCCTCGTTGCGCGACACCGCCTTCACCCTGGTCACCCGCCGTGCCACCTGGGAGCATCGGGCGGTCGTCGTCGGCGGGGGCGAGGAGGTCCTCGCCGGCCTCCGGGCCGTCGCCGGGGGACGTCCCGTCGACGGAGCCGTCAGCGGGCGGGCGCGCGCCGGCCGCCGGGTGGTGCTGGTCTTCCCCGGGCAGGGCGCACAGTGGCAGGGCATGGCCCGGGACCTGCTGCGGCAGTCGCCGACCTTCGCGGAGTCCATCGACGCCTGCGAGCGGGCGCTCGCCCCGCACGTGGACTGGTCGCTGCGCGAGGTGCTCGACGGCGAGCAGTCGTTGGACCCCGTCGACGTGGTGCAGCCGGTGCTGTTCGCGGTGATGGTGTCGTTGGCGCGGTTGTGGCAGTCGTACGGGGTGACTCCGGGTGCGGTGGTGGGTCACTCGCAGGGGGAGATCGCCGCCGCGCACGTGGCTGGTGCGTTGTCGTTGGCCGACGCCGCCAGGGTGGTGGCGTTGCGCAGCCGGGTGCTGCGCCGTCTCGGTGGTCACGGCGGGATGGCGTCGTTCGGGCTCCACCCCGACCAGGCCGCCGAGCGGATCGCGCGCTTCGCGGGTGCGCTGACTGTCGCCTCGGTCAACGGTCCCCGTTCGGTGGTGCTGGCCGGGGAGAACGGCCCGTTGGACGAGCTGATCGCCGAGTGCGAGGCCGAGGGCGTGACCGCCCGTCGGATCCCCGTCGACTACGCCTCACACTCCCCGCAGGTGGAGTCGCTGCGTGAGGAGCTGCTCGCCGCACTGGCCGGGGTCCGTCCGGTGTCGGCCGGGATCCCCCTGTACTCGACCCTGACCGGTCAGGTCATCGAAACGGCGACGATGGACGCCGACTACTGGTTCGCCAACCTCCGGGAGCCGGTGCGCTTCCAGGACGCCACCAGGCAGCTCGCCGAGGCGGGGTTCGACGCCTTCGTCGAGGTCAGCCCGCACCCGGTGTTGACAGTCGGTGTCGAGGCCACCCTCGAGGCAGTGCTGCCCCCCGACGCGGATCCGTGTGTCACAGGCACCCTGCGCCGCGAACGCGGCGGTCTCGCGCAGTTCCACACCGCGCTCGCCGAGGCGTACACCCGGGGGGTGGAGGTCGACTGGCGTACCGCAGTGGGTGAGGGACGCCCGGTCGACCTGCCGGTCTACCCGTTCCAACGACAGAACTTCTGGCTCCCGGTCCCCCTGGGCCGGGTCCCCGACACCGGCGACGAGTGGCGTTACCAGCTCGCCTGGCACCCCGTCGACCTCGGGCGGTCCTCCCTGGCCGGACGGGTCCTGGTGGTGACCGGAGCGGCAGTACCCCCGGCCTGGACGGACGTGGTCCGCGACGGCCTGGAACAGCGCGGGGCGACCGTCGTGTTGTGCACCGCGCAGTCGCGCGCCCGGATCGGCGCCGCACTCGACGCCGTCGACGGCACCGCCCTGTCCACTGTGGTCTCTCTGCTCGCGCTCGCCGAGGGCGGTGCTGTCGACGACCCCAGCCTGGACACCCTCGCGTTGGTCCAGGCGCTCGGCGCAGCCGGGATCGACGTCCCCCTGTGGCTGGTGACCAGGGACGCCGCCGCCGTGACCGTCGGAGACGACGTCGATCCGGCCCAGGCCATGGTCGGTGGGCTCGGCCGGGTGGTGGGCGTGGAGTCCCCCGCCCGGTGGGGTGGCCTGGTGGACCTGCGCGAGGCCGACGCCGACTCGGCCCGGTCGCTGGCCGCCATACTGGCCGACCCGCGCGGCGAGGAGCAGTTCGCGATCCGGCCCGACGGCGTCACCGTCGCCCGTCTCGTCCCGGCACCGGCCCGCGCGGCGGGTACCCGGTGGACGCCGCGCGGGACCGTCCTGGTCACCGGCGGCACCGGCGGCATCGGCGCGCACCTGGCCCGCTGGCTCGCCGGTGCGGGCGCCGAGCACCTGGTGCTGCTCAACAGGCGGGGAGCGGAGGCGGCCGGTGCCGCCGACCTGCGTGACGAACTGGTCGCGCTCGGCACGGGAGTCACCATCACGGCCTGCGACGTCGCCGACCGCGACCGGTTGGCGGCCGTCCTCGACGCCGCACGGGCGCAGGGACGGGTGGTCACGGCGGTGTTCCACGCCGCCGGGATCTCCCGGTCCACAGCGGTACAGGAGCTGACCGAGAGCGAGTTCACCGAGATCACCGACGCGAAGGTGCGGGGTACGGCGAACCTGGCCGAACTCTGTCCCGAGCTGGACGCCCTCGTGCTGTTCTCCTCGAACGCGGCGGTGTGGGGCAGCCCGGGGCTGGCCTCCTACGCGGCGGGCAACGCCTTCCTCGACGCCTTCGCCCGTCGTGGTCGGCGCAGTGGGCTGCCGGTCACCTCGATCGCCTGGGGTCTGTGGGCCGGGCAGAACATGGCCGGTACCGAGGGCGGCGACTACCTGCGCAGCCAGGGCCTGCGCGCCATGGACCCGCAGCGGGCGATCGAGGAGCTGCGGACCACCCTGGACGCCGGGGACCCGTGGGTGTCGGTGGTGGACCTGGACCGGGAGCGGTTCGTCGAACTGTTCACCGCCGCCCGCCGCCGGCCCCTCTTCGACGAACTCGGTGGGGTCCGCGCCGGGGCCGAGGAGACCGGTCAGGAATCGGATCTCGCCCGGCGGCTGGCGTCGATGCCGGAGGCCGAACGTCACGAGCATGTCGCCCGGCTGGTCCGAGCCGAGGTGGCAGCGGTGCTGGGCCACGGCACGCCGACGGTGATCGAGCGTGACGTCGCCTTCCGTGACCTGGGATTCGACTCCATGACCGCCGTCGACCTGCGGAACCGGCTCGCGGCGGTGACCGGGGTCCGGGTGGCCACGACCATCGTCTTCGACCACCCGACAGTGGACCGCCTCACCGCGCACTACCTGGAACGACTCGTCGGTGAGCCGGAGGCGACGACCCCGGCTGCGGCGGTCGTCCCGCAGGCACCCGGGGAGGCCGACGAGCCGATCGCGATCGTCGGGATGGCCTGCCGCCTCGCCGGTGGAGTGCGTACCCCCGACCAGTTGTGGGACTTCATCGTCGCCGACGGCGACGCGGTCACCGAGATGCCGTCGGACCGGTCCTGGGACCTCGACGCGCTGTTCGACCCGGACCCCGAGCGGCACGGCACCAGCTACTCCCGGCACGGCGCGTTCCTGGACGGGGCGGCCGACTTCGACGCGGCGTTCTTCGGGATCTCGCCGCGTGAGGCGTTGGCGATGGATCCGCAGCAGCGGCAGGTCCTGGAGACGACGTGGGAGCTGTTCGAGAACGCCGGCATCGACCCGCACTCCCTGCGCGGTACGGACACCGGTGTCTTCCTCGGCGCTGCGTACCAGGGGTACGGCCAGAACGCGCAGGTGCCGAAGGAGAGTGAGGGTTACCTGCTCACCGGTGGTTCCTCGGCGGTCGCCTCCGGTCGGATCGCGTACGTGTTGGGGTTGGAGGGGCCGGCGATCACTGTGGACACGGCGTGTTCGTCGTCGCTTGTGGCGTTGCACGTGGCGGCCGGGTCGCTGCGATCGGGTGACTGTGGGCTCGCGGTGGCGGGTGGGGTGTCGGTGATGGCCGGTCCGGAGGTGTTCACCGAGTTCTCCAGGCAGGGCGCGCTGGCCCCCGACGGTCGGTGCAAGCCCTTCTCCGACCAGGCCGACGGGTTCGGATTCGCCGAGGGCGTCGCTGTGGTGCTCCTGCAGCGGTTGTCGGTGGCGGTGCGGGAGGGGCGTCGGGTGTTGGGTGTGGTGGTGGGTTCGGCGGTGAATCAGGATGGGGCGAGTAATGGGTTGGCGGCGCCGTCGGGGGTGGCGCAGCAGCGGGTGATTCGGCGGGCGTGGGGTCGTGCGGGTGTGTCGGGTGGGGATGTGGGTGTGGTGGAGGCGCATGGGACGGGGACGCGGTTGGGGGATCCGGTGGAGTTGGGGGCGTTGTTGGGGACGTATGGGGTGGGTCGGGGTGGGGTGGGTCCGGTGGTGGTGGGTTCGGTGAAGGCGAATGTGGGTCATGTGCAGGCGGCGGCGGGTGTGGTGGGTGTGATCAAGGTGGTGTTGGGGTTGGGTCGGGGGTTGGTGGGTCCGATGGTGTGTCGGGGTGGGTTGTCGGGGTTGGTGGATTGGTCGTCGGGTGGGTTGGTGGTGGCGGATGGGGTGCGGGGGTGGCCGGTGGGTGTGGATGGGGTGCGTCGGGGTGGGGTGTCGGCGTTTGGGGTGTCGGGGACGAATGCTCATGTGGTGGTGGCGGAGGCGCCGGGGTCGGTGGTGGGGGCGGAACGGCCGGTGGAGGGGTCGTCGCGGGGGTTGGTGGGGGTGGCTGGTGGTGTGGTGCCGGTGGTGCTGTCGGCAAAGACCGAAACCGCCCTGACCGAGCTCGCCCGACGACTGCACGACGCCGTCGACGACACCGTCGCCCTCCCGGCGGTGGCCGCCACCCTCGCCACCGGACGCGCCCACCTGCCCTACCGGGCCGCCCTGCTGGCCCGCGACCACGACGAACTGCGCGACAGGCTGCGGGCGTTCACCACTGGTTCGGCGGCTCCCGGTGTGGTGTCGGGGGTGGCGTCGGGTGGTGGTGTGGTGTTTGTTTTTCCTGGTCAGGGTGGTCAGTGGGTGGGGATGGCGCGGGGGTTGTTGTCGGTTCCGGTGTTTGTGGAGTCGGTGGTGGAGTGTGATGCGGTGGTGTCGTCGGTGGTGGGGTTTTCGGTGTTGGGGGTGTTGGAGGGTCGGTCGGGTGCGCCGTCGTTGGATCGGGTGGATGTGGTGCAGCCGGTGTTGTTCGTGGTGATGGTGTCGTTGGCGCGGTTGTGGCGGTGGTGTGGGGTTGTGCCTGCGGCGGTGGTGGGTCATTCGCAGGGGGAGATCGCGGCGGCGGTGGTGGCGGGGGTGTTGTCGGTGGGTGATGGTGCGCGGGTGGTGGCGTTGCGGGCGCGGGCGTTGCGGGCGTTGGCCGGCCACGGCGGCATGGTCTCCCTCGCGGTCTCCGCCGAACGCGCCCGGGAGCTGATCGCACCCTGGTCCGACCGGATCTCGGTGGCGGCGGTCAACTCCCCGACCTCGGTGGTGGTCTCGGGTGACCCACAGGCCCTCGCCGCCCTCGTCGCCCACTGCGCCGAGACCGGTGAGCGGGCCAAGACGCTGCCTGTGGACTACGCCTCCCACTCCGCCCACGTCGAACAGATCCGCGACACGATCCTCACCGACCTGGCCGACGTCACGGCGCGCCGACCCGACGTCGCCCTCTACTCCACGCTGCACGGCGCCCGGGGCGCCGGCACGGACATGGACGCCCGGTACTGGTACGACAACCTGCGCTCACCGGTGCGCTTCGACGAGGCCGTCGAGGCCGCCGTCGCCGACGGCTACCGGGTCTTCGTCGAGATGAGCCCACACCCGGTCCTCACCGCCGCGGTGCAGGAGATCGACGACGAGACGGTGGCCATCGGCTCGCTGCACCGGGACACCGGCGAGCGGCACCTGGTCGCCGAACTCGCCCGGGCCCACGTGCACGGCGTACCAGTGGACTGGCGGGCGATCCTCCCCGCCACCCACCCGGTTCCCCTGCCGAACTACCCGTTCGAGGCGACCCGGTACTGGCTCGCCCCGACGGCGGCCGACCAGGTCGCCGACCACCGCTACCGCGTCGACTGGCGGCCCCTGGCCACCACCCCGGCGGAGCTGTCCGGCAGCTACCTCGTCTTCGGCGACGCCCCGGAGACCCTCGGCCACAGCGTCGAGAAGGCCGGCGGGCTCCTCGTCCCGGTGGCCGCTCCCGACCGGGAGTCCCTCGCGGTCGCCCTGGACGAGGCGGCCGGACGACTCGCCGGTGTGCTCTCCTTCGCCGCCGACACCGCCACCCACCTGGCCCGGCACCGACTCCTCGGCGAGGCCGACGTCGAGGCCCCACTCTGGCTGGTCACCAGCGGCGGCGTCGCACTCGACGACCACGACCCGATCGACTGCGACCAGGCAATGGTGTGGGGGATCGGACGGGTGATGGGTCTGGAGACCCCGCACCGGTGGGGCGGCCTGGTGGACGTGACCGTCGAACCCACCGCCGAGGACGGGGTGGTCTTCGCCGCCCTCCTGGCCGCCGACGACCACGAGGACCAGGTGGCGCTGCGCGACGGCATCCGCCACGGCCGACGGCTCGTCCGCGCCCCGCTGACCACCCGAAACGCCAGGTGGACACCGGCGGGCACGGCGCTCGTCACGGGCGGTACGGGTGCCCTCGGCGGCCACGTCGCGCGGTACCTGGCCCGGTCCGGGGTGACCGATCTCGTCCTGCTCAGCAGGAGCGGCCCCGACGCACCCGGTGCCGCCGAACTGGCCGCCGAACTGGCCGACCTCGGGGCCGAGCCGAGAGTCGAGGCGTGCGACGTCACCGACGGGCCACGCCTGCGCGCCCTGGTGCAGGAGCTACGGGAACAGGACCGGCCGGTCCGGATCGTCGTCCACACCGCAGGGGTGCCCGACTCCCGTCCCCTCGACCGGATCGACGAACTGGAGTCGGTCAGCGCCGCGAAGGTGACCGGGGCGCGGCTGCTCGACGAGCTCTGCCCGGACGCCGACACCTTCGTCCTGTTCTCCTCGGGGGCGGGAGTGTGGGGTAGCGCGAACCTGGGCGCGTACGCGGCAGCCAACGCCTACCTGGACGCCCTGGCCCACCGCCGCCGCCAGGCGGGCCGGGCCGCGACCTCGGTCGCCTGGGGGGCGTGGGCCGGCGACGGCATGGCCACCGGCGACCTCGACGGGCTGACCCGGCGCGGTCTGCGGGCGATGGCACCGGACCGGGCGCTGCGCGCCTGCACCAGGCGTTGGACCACCCACGACACCTGTGTGTCGGTAGCCGACGTCGACTGGGACCGCTTCGCCGTGGGTTTCACCGCCGCCCGGCCCAGACCCCTGATCGACGAACTCGTCACCTCCGCGCCGGTGGCCGCCCCCACCGCTGCGGCGGCCCCGGTCCCGGCGATGACCGCCGACCAGCTACTCCAGTTCACGCGCTCGCACGTGGCCGCGATCCTCGGTCACCAGGACCCGGACGCGGTCGGGTTGGACCAGCCCTTCACCGAGCTGGGCTTCGACTCGCTCACCGCCGTCGGCCTGCGCAACCAGCTCCAGCAGGCCACCGGGCGGACGCTGCCCGCCGCCCTGGTGTTCCAGCACCCCACGGTACGCAGACTCGCCGACCACCTCGCGCAGCAGCTCGACGTCGGCACCGCCCCGGTCGAGGCGACGGGCAGCGTCCTGCGGGACGGCTACCGGCGGGCCGGGCAGACCGGCGACGTCCGGTCGTACCTGGACCTGCTGGCGAACCTGTCGGAGTTCCGGGAGCGGTTCACCGACGCGGCGAGCCTGGGCGGACAGCTGGAACTCGTCGACCTGGCCGACGGATCCGGCCCGGTCACTGTGATCTGTTGCGCGGGCACTGCGGCGCTCTCCGGGCCGCACGAGTTCGCCCGACTCGCCTCGGCGCTGCGCGGCACCGTGCCGGTGCGCGCCCTCGCGCAACCCGGGTACGAGGCGGGTGAACCGGTGCCGGCGTCGATGGAGGCAGTGCTCGGGGTGCAGGCGGACGCGGTCCTCGCGGCACAGGGCGACACGCCGTTCGTGCTGGTCGGACACTCGGCGGGGGCCCTGATGGCGTACGCCCTGGCGACCGAGCTGGCCGACCGGGGCCACCCGCCACGTGGCGTCGTGCTCCTCGACGTGTACCCACCCGGTCACCAGGAGGCGGTGCACGCCTGGCTCGGCGAGCTGACCGCCGCCCTGTTCGACCACGAGACCGTACGGATGGACGACACCCGGCTCACGGCCCTGGGGGCGTACGACAGGCTGACCGGCAGGTGGCGTCCGAGGGACACCGGTCTGCCCACGCTGGTGGTGGCCGCCAGCGAGCCGATGGGGGAGTGGCCGGACGACGGTTGGCAGTCCACGTGGCCGTTCGGGCACGACAGGGTCACGGTGCCCGGTGACCACTTCTCGATGGTGCAGGAGCACGCCGACGCGATCGCGCGGCACATCGACGCCTGGTTGAGCGGGGAGAGGGCATGA	MSESSGMTEDRLRRYLKRTVAELDSVTGRLDEVEYRAREPIAVVGMACRFPGGVDSPEAFWEFIRDGGDAIAEAPTDRGWPPAPRPRLGGLLAEPGAFDAAFFGISPREALATDPQQRLMLEISWEALERAGFDPSSLRGSAGGVFTGVGAVDYGPRPDEAPEEVLGYVGIGTASSVASGRVAYTLGLEGPAVTVDTACSSGLTAVHLAMESLRRDECTLVLAGGVTVMSSPGAFTEFRSQGGLAEDGRCKPFSRAADGFGLAEGAGVLVLQRLSVARAEGRPVLAVLRGSAINQDGASNGLTAPSGPAQRRVIRQALERARLRPVDVDYVEAHGTGTRLGDPIEAHALLDTYGADREPGRPLWVGSVKSNIGHTQAAAGVAGVMKTVLALRHREIPATLHFDEPSPHVDWDRGAVSVVSETRPWPVGERPRRAGVSSFGISGTNAHVIVEEAPSPQAADLDPTPGPATGATPGTDAAPTAEPGAEAVALVFSARDERALRAQAARLADRLTDDPAPSLRDTAFTLVTRRATWEHRAVVVGGGEEVLAGLRAVAGGRPVDGAVSGRARAGRRVVLVFPGQGAQWQGMARDLLRQSPTFAESIDACERALAPHVDWSLREVLDGEQSLDPVDVVQPVLFAVMVSLARLWQSYGVTPGAVVGHSQGEIAAAHVAGALSLADAARVVALRSRVLRRLGGHGGMASFGLHPDQAAERIARFAGALTVASVNGPRSVVLAGENGPLDELIAECEAEGVTARRIPVDYASHSPQVESLREELLAALAGVRPVSAGIPLYSTLTGQVIETATMDADYWFANLREPVRFQDATRQLAEAGFDAFVEVSPHPVLTVGVEATLEAVLPPDADPCVTGTLRRERGGLAQFHTALAEAYTRGVEVDWRTAVGEGRPVDLPVYPFQRQNFWLPVPLGRVPDTGDEWRYQLAWHPVDLGRSSLAGRVLVVTGAAVPPAWTDVVRDGLEQRGATVVLCTAQSRARIGAALDAVDGTALSTVVSLLALAEGGAVDDPSLDTLALVQALGAAGIDVPLWLVTRDAAAVTVGDDVDPAQAMVGGLGRVVGVESPARWGGLVDLREADADSARSLAAILADPRGEEQFAIRPDGVTVARLVPAPARAAGTRWTPRGTVLVTGGTGGIGAHLARWLAGAGAEHLVLLNRRGAEAAGAADLRDELVALGTGVTITACDVADRDRLAAVLDAARAQGRVVTAVFHAAGISRSTAVQELTESEFTEITDAKVRGTANLAELCPELDALVLFSSNAAVWGSPGLASYAAGNAFLDAFARRGRRSGLPVTSIAWGLWAGQNMAGTEGGDYLRSQGLRAMDPQRAIEELRTTLDAGDPWVSVVDLDRERFVELFTAARRRPLFDELGGVRAGAEETGQESDLARRLASMPEAERHEHVARLVRAEVAAVLGHGTPTVIERDVAFRDLGFDSMTAVDLRNRLAAVTGVRVATTIVFDHPTVDRLTAHYLERLVGEPEATTPAAAVVPQAPGEADEPIAIVGMACRLAGGVRTPDQLWDFIVADGDAVTEMPSDRSWDLDALFDPDPERHGTSYSRHGAFLDGAADFDAAFFGISPREALAMDPQQRQVLETTWELFENAGIDPHSLRGTDTGVFLGAAYQGYGQNAQVPKESEGYLLTGGSSAVASGRIAYVLGLEGPAITVDTACSSSLVALHVAAGSLRSGDCGLAVAGGVSVMAGPEVFTEFSRQGALAPDGRCKPFSDQADGFGFAEGVAVVLLQRLSVAVREGRRVLGVVVGSAVNQDGASNGLAAPSGVAQQRVIRRAWGRAGVSGGDVGVVEAHGTGTRLGDPVELGALLGTYGVGRGGVGPVVVGSVKANVGHVQAAAGVVGVIKVVLGLGRGLVGPMVCRGGLSGLVDWSSGGLVVADGVRGWPVGVDGVRRGGVSAFGVSGTNAHVVVAEAPGSVVGAERPVEGSSRGLVGVAGGVVPVVLSAKTETALTELARRLHDAVDDTVALPAVAATLATGRAHLPYRAALLARDHDELRDRLRAFTTGSAAPGVVSGVASGGGVVFVFPGQGGQWVGMARGLLSVPVFVESVVECDAVVSSVVGFSVLGVLEGRSGAPSLDRVDVVQPVLFVVMVSLARLWRWCGVVPAAVVGHSQGEIAAAVVAGVLSVGDGARVVALRARALRALAGHGGMVSLAVSAERARELIAPWSDRISVAAVNSPTSVVVSGDPQALAALVAHCAETGERAKTLPVDYASHSAHVEQIRDTILTDLADVTARRPDVALYSTLHGARGAGTDMDARYWYDNLRSPVRFDEAVEAAVADGYRVFVEMSPHPVLTAAVQEIDDETVAIGSLHRDTGERHLVAELARAHVHGVPVDWRAILPATHPVPLPNYPFEATRYWLAPTAADQVADHRYRVDWRPLATTPAELSGSYLVFGDAPETLGHSVEKAGGLLVPVAAPDRESLAVALDEAAGRLAGVLSFAADTATHLARHRLLGEADVEAPLWLVTSGGVALDDHDPIDCDQAMVWGIGRVMGLETPHRWGGLVDVTVEPTAEDGVVFAALLAADDHEDQVALRDGIRHGRRLVRAPLTTRNARWTPAGTALVTGGTGALGGHVARYLARSGVTDLVLLSRSGPDAPGAAELAAELADLGAEPRVEACDVTDGPRLRALVQELREQDRPVRIVVHTAGVPDSRPLDRIDELESVSAAKVTGARLLDELCPDADTFVLFSSGAGVWGSANLGAYAAANAYLDALAHRRRQAGRAATSVAWGAWAGDGMATGDLDGLTRRGLRAMAPDRALRACTRRWTTHDTCVSVADVDWDRFAVGFTAARPRPLIDELVTSAPVAAPTAAAAPVPAMTADQLLQFTRSHVAAILGHQDPDAVGLDQPFTELGFDSLTAVGLRNQLQQATGRTLPAALVFQHPTVRRLADHLAQQLDVGTAPVEATGSVLRDGYRRAGQTGDVRSYLDLLANLSEFRERFTDAASLGGQLELVDLADGSGPVTVICCAGTAALSGPHEFARLASALRGTVPVRALAQPGYEAGEPVPASMEAVLGVQADAVLAAQGDTPFVLVGHSAGALMAYALATELADRGHPPRGVVLLDVYPPGHQEAVHAWLGELTAALFDHETVRMDDTRLTALGAYDRLTGRWRPRDTGLPTLVVAASEPMGEWPDDGWQSTWPFGHDRVTVPGDHFSMVQEHADAIARHIDAWLSGERA	MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQVLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYSPIAEKHVNGTMTLAELSAAVLQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL	1100.00	gnl|BL_ORD_ID|3483|hsp_num:0	4552			279	543	
BGC0000092.1|Megalomicin_16 # 43268 # 44344 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.758	BGC0000092.1|Megalomicin_16 	43268	44344	+	Loose	450	25.0238	VMB-1	27.08	3005015	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	VMB beta-lactamase	ATGAACACGACCGATCGCGCCGTGCTGGGCCGACGACTCCAGATGATCCGGGGACTGTACTGGGGTTACGGCAGCAACGGAGACCCGTACCCGATGCTGTTGTGCGGGCACGACGACGACCCGCACCGCTGGTACCGGGGGCTGGGCGGATCCGGGGTCCGGCGCAGCCGTACCGAGACGTGGGTGGTGACCGACCACGCCACCGCCGTGCGGGTGCTCGACGACCCGACCTTCACCCGGGCCACCGGCCGGACGCCGGAGTGGATGCGGGCCGCGGGCGCCCCGGCCTCGACCTGGGCGCAGCCGTTCCGTGACGTGCACGCCGCGTCCTGGGACGCCGAACTGCCCGACCCGCAGGAGGTGGAGGACCGGCTGACGGGTCTCCTGCCTGCCCCGGGGACCCGCCTGGACCTGGTCCGCGACCTCGCCTGGCCGATGGCGTCGCGGGGGGTCGGCGCGGACGACCCCGACGTGCTGCGCGCCGCGTGGGACGCCCGGGTCGGCCTCGACGCCCAGCTCACCCCGCAGCCCCTGGCGGTGACCGAGGCGGCGATCGCCGCGGTGCCCGGGGACCCGCACCGGCGGGCGCTGTTCACCGCCGTCGAGATGACAGCCACCGCGTTCGTCGACGCGGTGCTGGCGGTGACCGCCACGGCGGGGGCGGCCCAGCGTCTCGCCGACGACCCCGACGTCGCCGCCCGTCTCGTCGCGGAGGTGCTGCGCCTGCATCCGACGGCGCACCTGGAACGGCGTACCGCCGGCACCGAGACGGTGGTGGGCGAGCACACGGTCGCGGCGGGCGACGAGGTCGTCGTGGTGGTCGCCGCCGCCAACCGTGACGCGGGGGTCTTCGCCGACCCGGACCGCCTCGACCCGGACCGGGCCGACGCCGACCGGGCCCTGTCCGCCCAGCGCGGTCACCCCGGCCGGTTGGAGGAGCTGGTGGTGGTCCTGACCACCGCCGCACTGCGCAGCGTCGCCAAGGCGCTGCCCGGTCTCACCGCCGGTGGCCCGGTCGTCAGGCGACGTCGTTCACCGGTCCTGCGAGCCACCGCCCACTGCCCGGTCGAACTCTGA	MNTTDRAVLGRRLQMIRGLYWGYGSNGDPYPMLLCGHDDDPHRWYRGLGGSGVRRSRTETWVVTDHATAVRVLDDPTFTRATGRTPEWMRAAGAPASTWAQPFRDVHAASWDAELPDPQEVEDRLTGLLPAPGTRLDLVRDLAWPMASRGVGADDPDVLRAAWDARVGLDAQLTPQPLAVTEAAIAAVPGDPHRRALFTAVEMTATAFVDAVLAVTATAGAAQRLADDPDVAARLVAEVLRLHPTAHLERRTAGTETVVGEHTVAAGDEVVVVVAAANRDAGVFADPDRLDPDRADADRALSAQRGHPGRLEELVVVLTTAALRSVAKALPGLTAGGPVVRRRRSPVLRATAHCPVEL	MKYIILFLLLIPSIVFANNEGTKELKLKKLSDNVYQHISYKRVEPWGLIGASGLVVINGTEAHMIDTPWTTQGTKQLIEWIEAKGLTIKSAVVTHFHEDASGDIPLLNDLKIKTYATSLTNKLLKLNQKEVSSDEISSNTFEFIDGVASVFYPGAGHTEDNIVVWLPNEKILFGGCFVKSLKNKNLGYTGDANISEWPNSMQKVINRYPDAKLVVPGHGEVGDVSLLKHTQALALSAAASNKKINKD	144.94	gnl|BL_ORD_ID|2747|hsp_num:0	3758			111	255	ceftriaxone; amoxicillin; meropenem; imipenem; ampicillin; cefotaxime
BGC0000092.1|Megalomicin_17 # 44355 # 45623 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GAGG;rbs_spacer=8bp;gc_cont=0.714	BGC0000092.1|Megalomicin_17 	44355	45623	+	Loose	700	56.6102	oleI	28.46	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCGTCGTCTTCTCCTCCATGGCCAGCAAGAGCCACCTGTTCGGTCTCGTTCCCCTCGCCTGGGCCTTCCGCGCGGCGGGCCACGAGGTACGGGTCGTCGCCTCACCGGCTCTCACCGACGACATCACGGCGGCCGGACTGACGGCCGTACCGGTCGGCACCGACGTCGACCTTGTCGACTTCATGACCCACGCCGGGTACGACATCATCGACTACGTCCGCAGCCTGGACTTCAGCGAGCGGGACCCGGCCACCTCCACCTGGGACCACCTGCTCGGCATGCAGACCGTCCTCACCCCGACCTTCTACGCCCTGATGAGCCCGGACTCGCTGGTCGAGGGCATGATCTCCTTCTGTCGGTCGTGGCGACCCGACTGGTCGTCTGGACCGCAGACCTTCGCCGCGTCGATCGCGGCGACGGTGACCGGCGTGGCCCACGCCCGACTCCTGTGGGGACCCGACATCACGGTACGGGCCCGGCAGAAGTTCCTCGGGCTGCTGCCCGGACAGCCCGCCGCCCACCGGGAGGACCCCCTCGCCGAGTGGCTCACCTGGTCTGTGGAGAGGTTCGGCGGCCGGGTGCCGCAGGACGTCGAGGAGCTGGTGGTCGGGCAGTGGACGATCGACCCCGCCCCGGTCGGGATGCGCCTCGACACCGGGCTGAGGACGGTGGGCATGCGCTACGTCGACTACAACGGCCCGTCGGTGGTGCCGGACTGGCTGCACGACGAGCCGACCCGCCGACGGGTCTGCCTCACCCTGGGCATCTCCAGCCGGGAGAACAGCATCGGGCAGGTCTCCGTCGACGACCTGTTGGGTGCGCTCGGTGACGTCGACGCCGAGATCATCGCGACAGTGGACGAGCAGCAGCTCGAAGGCGTCGCCCACGTCCCGGCCAACATCCGTACGGTCGGGTTCGTCCCGATGCACGCACTGCTGCCGACCTGCGCGGCGACGGTGCACCACGGCGGTCCCGGCAGCTGGCACACCGCCGCCATCCACGGCGTGCCGCAGGTGATCCTGCCCGACGGCTGGGACACCGGGGTCCGCGCCCAGCGGACCGAGGACCAGGGGGCGGGCATCGCCCTGCCGGTGCCCGAGCTGACCTCCGACCAGCTCCGCGAGGCGGTGCGGCGGGTCCTGGACGATCCCGCCTTCACCGCCGGTGCGGCGCGGATGCGGGCCGACATGCTCGCCGAGCCGTCCCCCGCCGAGGTCGTCGACGTCTGTGCGGGGCTGGTCGGGGAACGGACCGCCGTCGGATGA	MRVVFSSMASKSHLFGLVPLAWAFRAAGHEVRVVASPALTDDITAAGLTAVPVGTDVDLVDFMTHAGYDIIDYVRSLDFSERDPATSTWDHLLGMQTVLTPTFYALMSPDSLVEGMISFCRSWRPDWSSGPQTFAASIAATVTGVAHARLLWGPDITVRARQKFLGLLPGQPAAHREDPLAEWLTWSVERFGGRVPQDVEELVVGQWTIDPAPVGMRLDTGLRTVGMRYVDYNGPSVVPDWLHDEPTRRRVCLTLGISSRENSIGQVSVDDLLGALGDVDAEIIATVDEQQLEGVAHVPANIRTVGFVPMHALLPTCAATVHHGGPGSWHTAAIHGVPQVILPDGWDTGVRAQRTEDQGAGIALPVPELTSDQLREAVRRVLDDPAFTAGAARMRADMLAEPSPAEVVDVCAGLVGERTAVG	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	99.53	gnl|BL_ORD_ID|1684|hsp_num:0	1824			897	1266	oleandomycin
BGC0000092.1|Megalomicin_18 # 45620 # 46591 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.749	BGC0000092.1|Megalomicin_18 	45620	46591	+	Loose	350	29.6462	vanM	29.33	3002911	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	ATGAGCACCGACGCCACCCACGTCCGGCTCGGCCGGTGCGCCCTGCTGACCAGCCGGCTCTGGCTGGGTACGGCAGCCCTCGCCGGCCAGGACGACGCCGACGCAGTACGCCTGCTCGACCACGCCCGTTCCCGGGGCGTCAACTGCCTCGACACCGCCGACGACGACTCTGCGTCGACCAGTGCCCAGGTCGCCGAGGAGTCGGTCGGCCGGTGGTTGGCCGGGGACACCGGTCGGCGGGAGGAGACCGTCCTGTCGGTGACGGTGGGTGTCCCACCGGGCGGGCAGGTCGGCGGGGGCGGCCTCTCCGCCCGGCAGATCATCGCCTCCTGTGAGGGCTCCCTGCGGCGTCTCGGTGTCGACCACGTCGACGTCCTTCACCTGCCCCGGGTGGACCGGGTGGAGCCGTGGGACGAGGTCTGGCAGGCGGTGGACGCCCTCGTGGCCGCCGGAAAGGTCTGTTACGTCGGGTCGTCGGGCTTCCCCGGATGGCACATCGTCGCCGCCCAGGAGCACGCCGTCCGCCGTCACCGCCTCGGCCTGGTGTCCCACCAGTGTCGGTACGACCTGACGTCGCGCCATCCCGAACTGGAGGTCCTGCCCGCCGCGCAGGCGTACGGGCTCGGGGTCTTCGCCAGGCCGACCCGCCTCGGCGGTCTGCTCGGCGGCGACGGTCCGGGCGCCGCAGCCGCACGGGCGTCGGGACAGCCGACGGCACTGCGCTCGGCGGTGGAGGCGTACGAGGTGTTCTGCAGAGACCTCGGCGAGCACCCCGCCGAGGTCGCACTGGCGTGGGTGCTGTCCCGGCCCGGTGTGGCGGGGGCGGTCGTCGGTGCGCGGACGCCCGGACGGCTCGACTCCGCGCTCCGCGCCTGCGGCGTCGCCCTCGGCGCGACGGAACTCACCGCCCTGGACGGGATCTTCCCCGGGGTCGCCGCAGCAGGGGCGGCCCCGGAGGCGTGGCTACGGTGA	MSTDATHVRLGRCALLTSRLWLGTAALAGQDDADAVRLLDHARSRGVNCLDTADDDSASTSAQVAEESVGRWLAGDTGRREETVLSVTVGVPPGGQVGGGGLSARQIIASCEGSLRRLGVDHVDVLHLPRVDRVEPWDEVWQAVDALVAAGKVCYVGSSGFPGWHIVAAQEHAVRRHRLGLVSHQCRYDLTSRHPELEVLPAAQAYGLGVFARPTRLGGLLGGDGPGAAAARASGQPTALRSAVEAYEVFCRDLGEHPAEVALAWVLSRPGVAGAVVGARTPGRLDSALRACGVALGATELTALDGIFPGVAAAGAAPEAWLR	MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWDNEHCRSAVLSPDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVCMDKSLAYIIAKNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQYDSKILIEQGVLGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERERIKEAAKNIYKALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLAVKE	94.17	gnl|BL_ORD_ID|1774|hsp_num:0	1924			441	666	vancomycin; teicoplanin
